| Financial burden of drugs prescribed for cancer-associated symptoms A Gupta, L Nshuti, US Grewal, R Sedhom, DK Check, HM Parsons, ... JCO Oncology Practice 18 (2), 140-147, 2022 | 32 | 2022 |
| Breadth and exclusivity of hospital and physician networks in US insurance markets JA Graves, L Nshuti, J Everson, M Richards, M Buntin, S Nikpay, Z Zhou, ... JAMA network open 3 (12), e2029419-e2029419, 2020 | 26 | 2020 |
| Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available: Study examines Medicare Part D coverage to quantify how often brand-name drugs are designated … SB Dusetzina, J Cubanski, L Nshuti, S True, J Hoadley, D Roberts, ... Health Affairs 39 (8), 1326-1333, 2020 | 16 | 2020 |
| Out-of-pocket costs of specialty medications for psoriasis and psoriatic arthritis treatment in the Medicare population SP Pourali, L Nshuti, SB Dusetzina JAMA dermatology 157 (10), 1239-1241, 2021 | 12 | 2021 |
| Out‐of‐Pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the medicare population VK Rathi, GA Scangas, RB Metson, R Xiao, L Nshuti, SB Dusetzina International forum of allergy & rhinology 12 (10), 1295-1298, 2022 | 7 | 2022 |
| Differences by race, religiosity, and mental health in preferences for life-prolonging treatment among medicare beneficiaries JJ Sanders, AI Berrier, L Nshuti, JA Tulsky, C Lindvall Journal of General Internal Medicine 34, 1981-1983, 2019 | 4 | 2019 |
| Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs. SB Dusetzina, J Cubanski, AW Roberts, J Hoadley, S True, L Nshuti, ... American Journal of Managed Care 27 (7), 2021 | 3 | 2021 |
| Differences by Race, Religion, and Mental Health in Preferences for Life-Prolonging Treatment in Adverse Health States: Results from a National Sample of Medicare Beneficiaries … J Sanders, A Berrier, L Nshuti, C Lindvall, J Tulsky Journal of Pain and Symptom Management 57 (2), 378-379, 2019 | 1 | 2019 |
| Physician patient sharing relationships within insurance plan networks JA Graves, D Lee, L Leszinsky, L Nshuti, S Nikpay, M Richards, ... Health services research 58 (5), 1056-1065, 2023 | | 2023 |
| Geographic Variation in Hospital-Based Physician Participation in Insurance Networks S Nikpay, L Nshuti, M Richards, MB Buntin, D Polsky, JA Graves JAMA Network Open 5 (5), e2215414-e2215414, 2022 | | 2022 |
| Limited benefit and high financial burden of drugs used to manage cancer-associated anorexia/cachexia syndrome (CACS). A Gupta, L Nshuti, US Grewal, R Sedhom, H Parsons, AH Blaes, ... Journal of Clinical Oncology 39 (28_suppl), 55-55, 2021 | | 2021 |
| Medicare part D plan coverage of brand-name drugs when generics are available SB Dusetzina, J Cubanski, L Nshuti, S True, J Hoadley, A Roberts, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 304-304, 2020 | | 2020 |
Stacie DusetzinaVanderbilt University Medical Center在 vanderbilt.edu 的电子邮件经过验证
